02 May 2025
02 May 2025
The US government has unveiled a plan to develop broad-spectrum vaccines for pandemic-prone viruses.
Eli Lilly鈥檚 strong quarterly results were overshadowed by CVS鈥檚 decision to favour Novo Nordisk鈥檚 Wegovy over Zepbound.
The London Cancer Hub has been identified as a key district for 鈥榝rontier innovation鈥� by London Mayor Sadiq Khan.
Biogen鈥檚 CEO Chris Vibacher said 鈥榓 new Biogen鈥� is emerging following the end of its multiple sclerosis treatments heyday.
A key focus of R&D in the PTSD therapeutic space is the development of new therapeutic options with improved efficacy.
Repare will obtain upfront and near-term payments of $4m and a 10% common equity position from DCx.
The therapy leverages the company鈥檚 intravitreal vector, R100, invented using the Therapeutic Vector Evolution platform.
Dimerix will receive an upfront payment of $30m from Amicus and up to $75m in development and regulatory milestone payments.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
